Over the past decade, cannabidiol (CBD) has been studied for numerous applications in thousands of different studies and trials. However, a new clinical trial has just been announced that might very well decode a much larger picture than ever before.
Researchers at McLean Hospital have just begun a human trial that will study the effects of sublingual CBD tinctures on human participants over the course of the next year. Specifically, researchers will examine how regular CBD use might mitigate feelings of anxiety—and improve quality of life.
Participants will be given sublingual (under the tongue) CBD about 3 times daily for 4 weeks. During that time, patients will not stray from their normal treatment regimen. Also during that period, participants will be evaluated on 3 major metrics: Perceived quality of life, sleep, and overall health.
To learn more, visit ClinicalTrials.gov.